The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation.

Slides:



Advertisements
Similar presentations
Working together to achieve nursing excellence in VTE Katrina Glaister Clinical Governance Facilitator (VTE Project Nurse) Salisbury NHS Foundation Trust.
Advertisements

LHD Logo Venous Thromboembolism Reducing the Risk DATE.
Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.
The Health Roundtable Lucrative Liaisons: Coder- Clinician Liaison Database Presenter: James Muller Royal Brisbane and Womens Hospital Innovation Poster.
The Health Roundtable Osteoarthritis Chronic Care Program (OACCP) Presenter: Matthew Jennings Hospital Code Name: Innovation Poster Session HRT1215 – Innovation.
Archway Healthcare Library Critically Appraised Topic (CAT) Compression stockings and the prevention of DVT Richard Peacock.
VTE in abdominal-pelvic surgery patients
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Deep Vein Thrombosis (DVT)
Derivation and Validation of a Prediction Tool for Venous Thromboembolism (VTE): A VERITY Registry Study Roopen Arya, Shankaranarayana Paneesha, Aidan.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
Towards a ANZ Hip Fracture Registry “Quality Care Costs Less”
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Drug and Therapeutics Committee Session 7A. Identifying Problems with Medicine Use: Indicator Studies.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
The Health Roundtable 3-3b_HRT1215-Session_McCallWHITE_BARWON_VIC Orthopaedic Flow Presenter: Martin McCall-White Geelong Innovation Poster Session HRT1215.
The Health Roundtable Charting a course for change for people with chronic illness: The St George experience Presenters: Linda Soars, Daniel Shaw, Karen.
The Health Roundtable CareTrack Australia Presenter: Natalie Hannaford Hospital Code Name: Innovation Poster Session HRT1215 – Innovation Awards Sydney.
The Health Roundtable FAST-NOF Fast, Appropriate, Safe Treatment for Fractured Neck of Femur Patients Presenter: Peter Mason Hospital QE2 Innovation Poster.
Evaluating the Performance of a Previously Reported Risk Score to Predict Venous Thromboembolism: A VERITY Registry Study Denise O'Shaughnessy, Peter Rose,
The Health Roundtable NSW Safe Clinical Handover Program Presenter: James Dunne Agency for Clinical Innovation Innovation Poster Session HRT1215 – Innovation.
The Health Roundtable Emergency general surgery model of care Presenter: Mr Douglas Stupart Innovation Poster Session HRT1215 – Innovation Awards Sydney.
Hospital acquired VTE Alert system Caroline Baglin Thrombophilia CNS.
The Health Roundtable Do Electronic Medication Systems Impact Patient Safety: What do the Frontline Clinicians Think? Debono, D. 1, Greenfield, D. 1, Black,
Venous Thromboembolism (VTE) Southern New Hampshire Medical Center Lynda Pittenger, RN, CPHQ Kathy Helberg, BSN,RN, CPHQ.
Clinical Handover Presenter: Ned Douglas
IMPLEMENTING GUIDELINES AND REDUCING PATIENT RISK OF VENOUS THROMBOEMBOLISM IN A LARGE UK TEACHING HOSPITAL Sharron Millen, Head of Clinical Pharmacy and.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
A Regional Approach to Improvement Julie Branter Associate Director for Clinical Governance and Patient Safety 21 September 2010 South West Strategic Health.
Risk assessment for VTE
Preventing Hospital Acquired Thrombosis Simon Noble Peggy Edwards.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
The Health Roundtable Early detection of patient deteriopration Presenter: (delegate name) Innovation Poster Session HRT1215 – Innovation Awards Sydney.
The Health Roundtable Whole of Northern Adelaide Local Health Network (NALHN) Pilot Presenter: Margot Mains Northern Adelaide Local Health Network Innovation.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
The Health Roundtable Consultant Led ABF meetings Presenter: Sharon LINTON Sir Charles Gairdner Hospital Innovation Poster Session HRT1215 – Innovation.
The Health Roundtable “Burdening the Shoulder? Don’t Shoulder the Burden!” Presenter: Judy Chen Hospital Code Name: The Prince of Wales Hospital Innovation.
Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.
The Health Roundtable Connecting Care in the Community Presenter: Nicole McDonald, Manager Ongoing and Complex Care, CCLHD Central Coast LHD - NSW Innovation.
DVT Prevention and Anticoagulant Management
Is it possible to improve the elective surgery waitlist framework in a sub regional health service? Presenter: Peter Simpson-White Elective Surgery Coordinator.
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
The Health Roundtable Hip and Knee Replacement Improvement Project – Patient Goal Driven Care Presenter: Peter Faulkner Bendigo Innovation Poster Session.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,
The Health Roundtable 1-1c_HRT1215-Session_TIBBY_TPCH_QLD A Consumer Partnership in Cardiac Risk Management Changing Traditional Cardiac Rehabilitation.
The Health Roundtable Improving the Accuracy of Medication Profiling Process Presenter: Prathna Singh, Prem Kumar Hospital Code Name: Counties Manukau.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Risk Assessment for VTE. Which of the following best describes you?
Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:
The Health Roundtable Improving Patient Flow in Orthopaedic Inpatients Presenter: Kathy Flanigan - Nursing Director Hospital QE11 – Vic Innovation Poster.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Developing a systems-based approach to VTE a UK perspective Dr Anita Thomas OBE, UK.
The Health Roundtable Postoperative IV Antibiotic Therapy for Children with Complicated Appendicitis: A Propensity Score-Matched Observational Study Presenter:
The Health Roundtable Implementing Systems Change in Chronic Disease in the Illawarra Shoalhaven Presenters: Paul van den Dolder & Franca Facci ISH LHD.
The Health Roundtable Electronic Medication Management Presenter: Dr Melissa Baysari UNSW Innovation Poster Session HRT1215 – Innovation Awards Sydney.
The Health Roundtable STREAMLINE PATIENT JOURNEY Presenter: Deborah Beckinsale Cancer Services, St George Hospital Innovation Poster Session HRT1215 –
Innovation Poster Session
The Health Roundtable Using ART to get Bang for Buck – Systematic prioritisation to deliver medication safety interventions Presenter: Sanjoy Nand Hospital.
The Health Roundtable Presenter: (delegate name) Hospital Code Name: Innovation Poster Session HRT1418 – Allied Health Improvement Group th October.
Dr Thomas Lloyd F1 Dr Aman Hargehandewal Wrexham Maelor Hospital
Dr. Lesbia Adalgisa Rodriguez PGY3-Cook County Loyola Family Medicine Residency Program Venous Thromboembolism Prophylaxis in the Inpatient Setting.
Dr N Mudondo (FY2) Mr C Chatzdimitriou (SpR Breast Surgery) Mr M Haider (SpR Breast Surgery)
Venous Thromboembolism Prophylaxis (VTE)
VTE Education, Education, Education!
The Burden of Hospital-Associated Venous Thromboembolism
Preventing VTE in hospitalised patients
Irish Hip Fracture Database
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

The Health Roundtable 3-3c_HRT1215-Session_HANNAFORD_UNSW_NSW How many people received appropriate VTE prophylaxis? Presenter: Natalie Hannaford UNSW Innovation Poster Session HRT1215 – Innovation Awards Sydney 11 th and 12 th Oct

The Health Roundtable KEY PROBLEM  Approx 30,000 people are hospitalised due to VTE each year and about 2000 of those die (NHMRC 2009)  PE is responsible for about 10% of all hospital deaths (NHMRC, 2009)  The annual economic burden of VTE in Australia has been estimated to be as high as $21 Billion (Access Economics 2008)  An international audit of 70,000 patients, including Australia, found that only 50% of at-risk patients were receiving appropriate prophylaxis (Endorse study 2008; Cohen et al) 2

The Health Roundtable AIM OF THE STUDY  To translate the evidence contained in the guidelines to measurable clinical indicators  To determine how many Australian patients in our sample admitted to hospital during 2009 and 2010 received appropriate VTE prophylaxis. 3

The Health Roundtable Method  Developed 39 clinical indicators from the NHMRC 2009 VTE prophylaxis guidelines and the ANZWP VTE prevention 2007 guidelines  Patients admitted to hospital were risk assessed for VTE  Patients having a total hip replacement were prescribed graduated compression stockings  Ratified and endorsed by 3 clinical experts  Conducted a retrospective on site medical record review using a web based encrypted data collection tool  485 participants admitted to public and private hospitals in NSW and SA 4

The Health Roundtable RESULTS  Overall compliance - 58% (95%CI 53.3% %)  Admitted patients risk assessed for VTE – 69%  Aggregated results  surgical cases prescribed appropriate medication – 39%  Hip replacement medication compliance - 55%  Knee replacement medication compliance – 49%  medical admissions prescribed appropriate medication – 46%  Cancer patients with active cancer or undergoing surgery (meds & dev) – 32% 5

The Health Roundtable RESULTS  Patients with a suspected DVT had appropriate tests- 84.6%  Patients with suspected PE had appropriate tests – 81%  Patients administered heparin therapy had it continued until the INR was therapeutic for 48 hours – 51.2% 6

The Health Roundtable LESSONS LEARNT  Overall compliance was less than adequate and surprising for some conditions (orthopaedic surgery).  Obvious that some hospitals had implemented formal VTE risk assessment tools into admission documentation, but many had no means of recording/assessing this.  Still a lot of work to be done in this area to increase compliance and to understand why it remains low. 7